Vamotinib is a potent, selective tyrosine kinase inhibitor with oral activity. Vamotinib inhibits the autophosphorylation of BCR/ABL and BCR/ABL-T315I. Vamotinib shows anti-proliferative and anti-tumor activity. Vamotinib has potential in the study of drug-resistant Philadelphia chromosome-positive (Ph+) leukemia.
- Size: 5mg
- Purity: ≥98%
- Molecular Formula: C 2 9 H 2 7 F 3 N 6 O
- Molecular Weight: 532.56
- Physical State: Off-white to light yellow Solid
- Storage: Powder:2-8℃, 2 years;Insolvent(mother liquid):-20℃, 6 months;-80℃, 1 year
- Brand: Saint Michael
- Catalogue No.: IV1650-5mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review